Phase I Study of Ventricle Infusions of Autologous Ex Vivo-Expanded NK Cells in Children with Recurrent/Refractory Malignant Posterior Fossa Tumors of the Central Nervous System - NOAH's (New Opportunity, Advancing Hope) Protocol
MD Anderson Study Status
Natural Killer Cell Therapy
This phase I trial studies the side effects and best dose of expanded natural killer cells in treating younger patients with brain tumors that have come back or do not respond to treatment. Infusing a particular type of a patient's own white blood cells called natural killer cells that have been through a procedure to expand (increase) their numbers may work in treating patients with recurrent/refractory brain tumors.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Recurrent Childhood Medulloblastoma, Recurrent Ependymoma, Recurrent Medulloblastoma
For general questions about clinical trials:
Due to our response to COVID-19, all blood donations at MD Anderson
Blood Donor Center locations are being held by appointment only.